Screen Resolution:     
Welcome to HRGRN
A Graph Search-Empowered Integrative Database of Arabidopsis Signaling Transduction, Metabolism and Gene Regulation Networks   
Location:  Home > Details for node alpha-Cryptoxanthin
Type: Compound GRN ID: nc65981 Name: alpha-Cryptoxanthin
Annotation: alpha-Cryptoxanthin; (3'R,6'R)-beta,epsilon-Caroten-3'-ol
KEGG Acc.: C15981
CHEBI ID:
Formula: C40H56O
M.W.: 552.872
Graph Customization
   
Choose color for highlight:  
Display edge: validated and predicted
Display node/edge prompt:
Layout:
 as format     
Data Filter
 Protein modification
 Protein-protein interaction
        also include predicted relationship
 Compound-protein interaction
 TF-target gene regulation
 Small RNA-target regulation
        also include predicted relationship
 Carrier and transported molecule
 Catalytic chemical reaction
 Co-expressed gene pair
        with mutual information value >

  Ignore nodes having > relationships
 
Relationship type:  protein modification     catalytic chemical reaction     protein-protein interaction    
compound-protein interaction     TF-target gene regulation     small RNA-target regulation    
co-expressed gene pair     carrier and transported molecule     family/complex and member
Relationship evidence:  Solid line: validated          Dashed line: predicted
Relationship direction: Arrow: positive          T shape: negative          None arrow: unknown or n/a
Hormone association: Thicker line: hormone related relationship         : hormone related Node
Node type:  Transcription factor or transcriptional regulator       Compound       Kinase
 Small regulatory RNA (miRNA & ta-siRNA)       Other nodes
No. Path
2 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1
3 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  Reduced acceptor
4 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  alpha-Carotene
5 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  has similar expression pattern (mutual information value=1.0409) with  --  AT2G32640
6 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  has similar expression pattern (mutual information value=1.36486) with  --  ATFC-II; FC-II; FC2
7 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  has similar expression pattern (mutual information value=0.995729) with  --  AT2G38330
8 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  has similar expression pattern (mutual information value=0.993275) with  --  AT2G03420
9 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  has similar expression pattern (mutual information value=1.12413) with  --  AT1G27480
10 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  has similar expression pattern (mutual information value=0.941629) with  --  AT3G19480
11 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  has similar expression pattern (mutual information value=0.962793) with  --  AT3G20270
12 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  has similar expression pattern (mutual information value=0.898994) with  --  AT3G10840
13 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  has similar expression pattern (mutual information value=1.05075) with  --  HCF101
14 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  has similar expression pattern (mutual information value=1.14432) with  --  AT3G22210
15 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  has similar expression pattern (mutual information value=1.29892) with  --  AT4G10300
16 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  has similar expression pattern (mutual information value=1.24128) with  --  EMB3129
17 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  has similar expression pattern (mutual information value=1.07183) with  --  AT4G11100
18 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  has similar expression pattern (mutual information value=1.13613) with  --  DEG5; DEGP5; HHOA
19 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  has similar expression pattern (mutual information value=1.05238) with  --  AT4G19985
20 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  has similar expression pattern (mutual information value=1.03067) with  --  ATCBL10; CBL10; SCABP8
21 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  has similar expression pattern (mutual information value=0.925237) with  --  ALDH3; ALDH3I1
22 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  has similar expression pattern (mutual information value=1.23727) with  --  AT3G44020
23 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  has similar expression pattern (mutual information value=0.820839) with  --  AT3G47560
24 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  has similar expression pattern (mutual information value=0.852803) with  --  AT5G05880
25 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  has similar expression pattern (mutual information value=0.870227) with  --  ZFN3
26 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  has similar expression pattern (mutual information value=0.965337) with  --  ATMGT10; GMN10; MGT10; MGT10; MRS2-11
27 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  has similar expression pattern (mutual information value=1.02978) with  --  AT5G42310
28 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  has similar expression pattern (mutual information value=1.16774) with  --  AT5G45170
29 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  has similar expression pattern (mutual information value=1.08405) with  --  CYP97A3; LUT5
30 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  has similar expression pattern (mutual information value=0.941243) with  --  AT5G19500
31 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  has product (in catalytic reaction)  --  Acceptor
32 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  interacts with  --  CLI1; RPK2; TOAD2
33 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  interacts with  --  PIP1;3; PIP1C; TMP-B
34 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  interacts with  --  NRT1.9
35 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  interacts with  --  AT1G80890
36 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  interacts with  --  AT5G10290
37 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  interacts with  --  AT1G71140
38 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  interacts with  --  AT5G49130
39 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  interacts with  --  AT1G06890
40 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  CYP97C1; LUT1  --  interacts with  --  AT3G13670
41 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  Reduced acceptor  --  has product (in catalytic reaction)  --  Hydrogen selenide
42 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  Reduced acceptor  --  has product (in catalytic reaction)  --  CO
43 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  Reduced acceptor  --  has product (in catalytic reaction)  --  Biliverdin
44 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  Reduced acceptor  --  has product (in catalytic reaction)  --  Oleoyl-[acyl-carrier protein]
45 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  Reduced acceptor  --  is product (in catalytic reaction) of  --  CI76; EMB1467
46 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  Reduced acceptor  --  is product (in catalytic reaction) of  --  AT5G11770
47 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  Reduced acceptor  --  is product (in catalytic reaction) of  --  CI51
48 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  Reduced acceptor  --  is product (in catalytic reaction) of  --  AT4G02580
49 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  Reduced acceptor  --  is product (in catalytic reaction) of  --  AT1G79010
50 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  Reduced acceptor  --  is product (in catalytic reaction) of  --  AT1G16700
51 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  Reduced acceptor  --  is product (in catalytic reaction) of  --  ATCKX3
52 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  Reduced acceptor  --  is product (in catalytic reaction) of  --  iP
53 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  Reduced acceptor  --  is product (in catalytic reaction) of  --  AtCKX7
54 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  Reduced acceptor  --  is product (in catalytic reaction) of  --  ATCKX4
55 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  Reduced acceptor  --  is product (in catalytic reaction) of  --  ATCKX6
56 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  Reduced acceptor  --  is product (in catalytic reaction) of  --  ATCKX1
57 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  Reduced acceptor  --  is product (in catalytic reaction) of  --  ATCKX2
58 alpha-Cryptoxanthin  --  is product (in catalytic reaction) of  --  Reduced acceptor  --  is product (in catalytic reaction) of  --  ATCKX5
   Funding by the National Science Foundation    Funding by the Oklahoma Center for the Advancement of Science & Technology    Additional funding by the Samuel Roberts Noble Foundation

Copyright © The Zhao Lab

Disclaimer | Contact